3801811000001105: Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\UK product\Virtual medicinal product\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\UK product\Virtual therapeutic moiety\Auranofin\Product containing only auranofin in oral dose form (medicinal product form)\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\UK product\Virtual therapeutic moiety\Auranofin\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\UK product\Trade family\Ridaura\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing auranofin\Auranofin\Product containing only auranofin in oral dose form (medicinal product form)\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing auranofin\Auranofin\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing auranofin\Product containing auranofin in oral dose form (medicinal product form)\Product containing only auranofin in oral dose form (medicinal product form)\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing metal and/or metallic compound (product)\Product containing gold and/or gold compound (product)\Product containing auranofin\Auranofin\Product containing only auranofin in oral dose form (medicinal product form)\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing metal and/or metallic compound (product)\Product containing gold and/or gold compound (product)\Product containing auranofin\Auranofin\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by structure\Product containing metal and/or metallic compound (product)\Product containing gold and/or gold compound (product)\Product containing auranofin\Product containing auranofin in oral dose form (medicinal product form)\Product containing only auranofin in oral dose form (medicinal product form)\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antirheumatic agent (product)\Product containing auranofin\Auranofin\Product containing only auranofin in oral dose form (medicinal product form)\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antirheumatic agent (product)\Product containing auranofin\Auranofin\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antirheumatic agent (product)\Product containing auranofin\Product containing auranofin in oral dose form (medicinal product form)\Product containing only auranofin in oral dose form (medicinal product form)\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)
\Medicinal product\Product manufactured as oral dose form\Product containing auranofin in oral dose form (medicinal product form)\Product containing only auranofin in oral dose form (medicinal product form)\Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet\Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

17797701000001115 Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

38283001000001113 Ridaura Tiltab 3mg tablets (Astellas Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Is a	Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Has excipient	Propylene glycol	false	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Has active ingredient	Auranofin	false	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Is a	Ridaura	true	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Has specific active ingredient	Auranofin	true	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	VMP non-availability indicator	Not available	false	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	VMP non-availability indicator	Re-introduced	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals) 60 tablet	Is pack of	False	Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Inferred relationship	Existential restriction modifier
Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals) 60 tablet	Has AMP	True	Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
17797701000001115	Ridaura Tiltab 3mg tablets (Yamanouchi Pharmaceuticals) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
38283001000001113	Ridaura Tiltab 3mg tablets (Astellas Pharma Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module